-
How investors killed AstraZeneca’s $400bn megadeal
Tie-up with US rival Bristol Myers would have marked return to big pharma mergers
-
Humans cannot remain passengers in the back of the AGI car
A sense of fatalistic inevitability about the technology’s evolution is triggering something close to despair
-
Volatility tumbles as markets shrug off Middle East risks
Investors warn of complacency as Vix ‘fear gauge’ falls to prewar levels even as oil rises back to about $90 a barrel
-
China tightens grip on Europe’s car supply chain
Acquisitions of local parts makers amid resistance to Chinese exports have worried EU officials
-
Carbon tax will hit EU’s budget airlines where it hurts
Plans for a wider levy could benefit the bloc’s long-haul carriers but do little for low-cost operators
-
Spain’s migrant amnesty a ‘very bad idea’, says Swedish PM
Ulf Kristersson says mass regularisation threatens integrity of Schengen free-travel zone
-
Does Africa have too few people?
What some see as an alarming population explosion could be just what the continent needs
-
Maga ignores the many meanings of Mount Rushmore
South Dakota’s Black Hills are central to Lakota Nation cosmology and identity
Recent Posts
- How should investors position for the robot apocalypse?
- Unpacking the real fiscal costs of immigration
- I’ve covered wine for 50 years. Here are 50 ways it changed
- Investors weigh whether Anthropic can sustain surging revenues post-IPO
- Google’s Gemini agents hacked three companies in new AI safety incident
